Moreover, the presence of BRCA1 and BRCA2 mutations in PCa patients increased the risk of developing other tumors, such as male breast cancer, cancer of the pancreas, and melanoma, as compared with the incidence in the general population. This evidence concerns the gene BRCA1 and male breast carcinoma.